Frovocimab
Frovocimab (LY 3015014) is a humanized IgG4 monoclonal antibody to Subtilisin/Kexin Protein Converting Enzyme Type 9 (PCSK9) that binds to the catalytic domain of PCSK9 and lowers low-density lipoprotein cholesterol (LDL-C) in patients with hypercholesterolemia.Frovocimab is used in the study of hypercholesterolemia. Frovocimab is used to study hypercholesterolemia.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Others
CAS Number
1643672-70-1
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1008232-01 0.02 mg (E-Coli)
Recombinant Escherichia coli O78:H11 Heat-labile enterotoxin A chain (eltA)
Ask
View Details 
MBS1008232-02 0.1 mg (E-Coli)
Recombinant Escherichia coli O78:H11 Heat-labile enterotoxin A chain (eltA)
Ask
View Details MBS1008232-03 0.02 mg (Yeast)
Recombinant Escherichia coli O78:H11 Heat-labile enterotoxin A chain (eltA)
Ask
View Details MBS1008232-04 0.1 mg (Yeast)
Recombinant Escherichia coli O78:H11 Heat-labile enterotoxin A chain (eltA)
Ask
View Details 
MBS1008232-05 0.02 mg (Baculovirus)
Recombinant Escherichia coli O78:H11 Heat-labile enterotoxin A chain (eltA)
Ask
View Details 
MBS1008232-06 0.02 mg (Mammalian-Cell)
Recombinant Escherichia coli O78:H11 Heat-labile enterotoxin A chain (eltA)
Ask
View Details